Literature DB >> 9178461

Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles.

G De Serres1, J R Joly, M Fauvel, F Meyer, B Mâsse, N Boulianne.   

Abstract

Neutralizing antibody titers of 47 infants whose mothers sustained measles (measles group) and 70 whose mothers were vaccinated (vaccine group) were compared at birth, 4 and 8 months of age. All children had antibodies at birth and 88% at 4 months. At 8 months, 49% had antibodies in the measles group and 15% in the vaccine group (P < 0.001). The geometric mean titers were significantly lower in the vaccine group than in the measles group and the difference corresponded to the antibody loss occurring in only 1.5 months of life. This small difference may reflect past exposure to wild virus of many vaccinated mothers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178461     DOI: 10.1016/s0264-410x(96)00283-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

2.  Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Authors:  Chao Ma; Fangjun Li; Xiang Zheng; Hong Zhang; Mengjuan Duan; Yanhua Yang; Lixin Hao; Qiru Su; Lance Rodewald; Bosong Guo; Shanliang Xiao; Huaqing Wang; Li Li; Junhua Li; Huiming Luo; Lidong Gao
Journal:  BMC Infect Dis       Date:  2015-01-22       Impact factor: 3.090

3.  Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites.

Authors:  Papa M Drame; Anne Poinsignon; Célia Dechavanne; Gilles Cottrell; Manon Farce; Rodolphe Ladekpo; Achille Massougbodji; Sylvie Cornélie; David Courtin; Florence Migot-Nabias; André Garcia; Franck Remoué
Journal:  Malar J       Date:  2015-07-22       Impact factor: 2.979

4.  Timeliness vaccination of measles containing vaccine and barriers to vaccination among migrant children in East China.

Authors:  Yu Hu; Qian Li; Shuying Luo; Linqiao Lou; Xiaohua Qi; Shuyun Xie
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps.

Authors:  Niyi Awofeso; Anu Rammohan; Kazi Iqbal
Journal:  BMC Public Health       Date:  2013-04-17       Impact factor: 3.295

6.  Measles susceptibility in maternal-infant dyads-Bamako, Mali.

Authors:  Meredith G Dixon; Milagritos D Tapia; Kathleen Wannemuehler; Richard Luce; Mark Papania; Samba Sow; Myron M Levine; Marcela F Pasetti
Journal:  Vaccine       Date:  2022-01-31       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.